Glycoprotein IIB/IIIA inhibitor

Revisión del 01:22 22 oct 2020 de ClaireLewis (discusión | contribs.)
(difs.) ← Revisión anterior | Revisión actual (difs.) | Revisión siguiente → (difs.)

Background

  • By competing with fibrinogen and von Willebrand factor (vWF) for GP IIb/IIIa binding, GP IIb/IIIa antagonists interfere with platelet cross-linking and platelet-derived thrombus formation
  • Mostly indicated for patients undergoing PCI for ACS

Glycoprotein IIB/IIIA inhibitors

Obtenido de «https://www.wikem.org/w/index.php?title=Glycoprotein_IIB/IIIA_inhibitor&oldid=279662»
Authors: